查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951302

獸醫感染疾病診斷市場－全球產業規模、佔有率、趨勢、機會及預測（按技術、動物種類、最終用戶、地區和競爭格局分類，2021-2031年）

Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Animal Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫感染疾病診斷市場預計將從 2025 年的 16.1 億美元成長到 2031 年的 21.9 億美元，複合年成長率為 5.26%。

該領域涵蓋各種實驗室設備、試劑和免疫診斷試劑盒，這些對於檢測家畜和伴侶動物體內的細菌、病毒和寄生蟲病原體至關重要。推動這一成長的關鍵因素包括跨境通用感染疾病的日益流行，以及透過有效的動物健康管理來確保全球糧食安全的經濟需求。此外，寵物人性化的趨勢促使飼主更願意投資先進的醫療保健，從而刺激了對快速、準確病原體檢測的需求。世界動物衛生組織（OIE）的數據也印證了這項需求的迫切性：2024年1月至2025年5月期間，該組織記錄了14,918例非洲豬瘟病例和6,346例高致病性禽流感病例。

市場概覽
預測期 2027-2031
市場規模：2025年 16.1億美元
市場規模：2031年 21.9億美元
複合年成長率：2026-2031年 5.26%
成長最快的細分市場 分子診斷
最大的市場 北美洲

儘管成長要素強勁，但由於先進分子診斷技術實施和營運成本高昂，市場仍面臨許多障礙。這些資金限制往往阻礙了發展中地區採用先進的檢測方法，因為這些地區的獸醫預算有限，農業部門對價格仍然十分敏感。因此，這種經濟障礙阻礙了許多感染疾病疫源地廣泛採用尖端診斷技術，對全球市場的均衡擴張構成重大阻礙。

市場促進因素

跨境動物疫病和通用感染疾病的日益蔓延是市場擴張的主要驅動力，這要求各國政府和農業機構優先實施嚴格的監測系統，以確保糧食安全。對生物安全的重視加速了先進診斷劑和設備的採購，這些試劑和設備能夠快速識別牲畜體內的病原體。為了因應這些脆弱性，大量資金正投入加強檢測基礎設施建設。例如，2024年5月，美國農業部宣布通過《農業法案》撥款超過2,220萬美元，用於81個旨在加強對威脅性動物疫病早期檢測和快速反應能力的計劃。這筆資金將直接用於支持診斷技術的應用，以減少經濟損失。

同時，寵物飼養量的增加和寵物人性化的趨勢正在從根本上改變獸醫服務的結構，導致診斷和預防保健方面的支出不斷成長。隨著飼主越來越將寵物視為家庭成員，他們更願意為先進的醫學檢測付費，這促使診所擴大其內部檢測能力。美國寵物用品協會 (APPA) 2024 年 8 月的報告也反映了這一趨勢，該報告預測，到 2024 年，美國獸醫保健及相關產品的總支出將達到 398 億美元。產業領導者也支持這項需求，IDEXX Laboratories 在 2025 年公佈的 2024 年全年銷售額為 38.98 億美元。這凸顯了診斷產業的盈利，而這正是由上述兩大市場力量所驅動的。

市場挑戰

市場擴張的一大障礙是實施和營運先進分子診斷技術的高成本。這些精準檢測平台需要大量的資金投入，並且依賴昂貴的試劑，這對於預算有限的畜牧養殖戶和獸醫診所來說構成了很高的進入門檻。在對價格敏感的農業部門和發展中地區，這種經濟負擔往往迫使醫療專業人員依賴準確性較低的傳統方法，而不是採用現代診斷方案，從而限制了市場在感染疾病高風險地區的潛在擴張。

獸醫護理成本的整體上漲加劇了這一經濟負擔，限制了可用於高品質診斷服務的可支配收入。根據美國動物醫院協會 (AAHA) 統計，2025 年犬隻的終身醫療費用較 2022 年增加了 11.65%。不斷上漲的成本迫使農場主和寵物飼主仔細審查支出，越來越避免高成本的診斷程序，而選擇基本的症狀治療。因此，這種經濟限制直接阻礙了收入成長和先進診斷工具在全球的普及。

市場趨勢

將人工智慧 (AI) 和機器學習融入診斷領域的趨勢正在從根本上改變獸醫學的實踐，它能夠自動化複雜的分析任務並提高診斷準確性。這一趨勢透過將深度學習演算法整合到分析儀中，解決了專家短缺的問題，使臨床醫生能夠即時獲得細胞學和血液學檢測的參考級解讀結果。這項技術飛躍在近期的發展中得到了充分體現。 2024 年 12 月，碩騰公司 (Zoetis Inc.) 宣布對其 Vetscan Imagyst 平台進行人工智慧驅動的更新，透過引入可在數分鐘內識別和區分白血球的新演算法，簡化了診斷工作流程。

同時，就地檢驗(POC) 和快速診斷檢測 (RDT) 的引入，已將感染疾病控制從中心檢查室轉移到醫療點，從而能夠即時檢測病原體。獸醫可以利用現場分析儀快速實施生物安全措施和治療方案，為控制傳染病爆發提供了關鍵能力。市場向這些解決方案的轉變在財務表現中顯而易見。 2024 年 10 月，IDEXX Laboratories, Inc. 報告稱，其全球高階設備安裝量年增 10%，證實了診所對快速院內診斷基礎設施的投資不斷增加。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球獸醫感染疾病診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術分類（免疫診斷、分子診斷、其他獸醫診斷技術）
    • 動物類型（伴侶動物、肉類動物）
    • 依最終使用者（參考實驗室、獸醫實驗室/診所、照護現場/院內檢測、研究機構/大學）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美獸醫感染疾病診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲獸醫感染疾病診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區獸醫感染疾病診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲獸醫感染疾病診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲獸醫感染疾病診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球獸醫感染疾病診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BIOMeRIEUX
  • Heska Corporation
  • Neogen Corporation
  • INDICAL BIOSCIENCE GmbH
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • DRG INSTRUMENTS GMBH
  • Chembio Diagnostic Systems, Inc.
  • Eurofins Technologies
  • Agrolabo SpA
  • Abbott Laboratories inc.
  • Danaher Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20066

The Global Veterinary Infectious Disease Diagnostics Market is projected to expand from USD 1.61 Billion in 2025 to USD 2.19 Billion by 2031, reflecting a compound annual growth rate of 5.26%. This sector encompasses a variety of laboratory instruments, reagents, and immunodiagnostic kits essential for detecting bacterial, viral, and parasitic pathogens in livestock and companion animals. Key drivers propelling this growth include the rising prevalence of transboundary zoonotic diseases and the economic imperative to ensure global food security through effective herd health management. Additionally, the trend of pet humanization has increased owner willingness to fund advanced healthcare, thereby stimulating demand for rapid and precise pathogen detection. The urgency of this demand is highlighted by World Organisation for Animal Health data, which recorded 14,918 outbreaks of African swine fever and 6,346 outbreaks of high pathogenicity avian influenza between January 2024 and May 2025.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.61 Billion
Market Size 2031USD 2.19 Billion
CAGR 2026-20315.26%
Fastest Growing SegmentMolecular Diagnostics
Largest MarketNorth America

Despite these strong growth drivers, the market encounters significant obstacles due to the high acquisition and operational costs associated with advanced molecular diagnostic technologies. These financial constraints frequently limit the adoption of precise testing methods in developing regions where veterinary budgets are restricted and agricultural sectors remain price-sensitive. Consequently, this economic barrier hampers the widespread deployment of state-of-the-art diagnostics in areas where many infectious outbreaks originate, creating a substantial impediment to the uniform expansion of the global market.

Market Driver

The escalating prevalence of transboundary and zoonotic animal diseases serves as a primary engine for market expansion, necessitating that governments and agricultural bodies prioritize rigorous surveillance systems to ensure food security. This focus on biosecurity accelerates the procurement of advanced diagnostic reagents and instruments capable of rapid pathogen identification in livestock. To address these vulnerabilities, significant financial resources are being allocated to strengthen detection infrastructure. For instance, the U.S. Department of Agriculture announced in May 2024 that it awarded over $22.2 million in Farm Bill funding to 81 projects aimed at enhancing early detection and rapid response capabilities for threatening animal diseases, directly subsidizing the adoption of diagnostic technologies to mitigate economic losses.

Simultaneously, the rising adoption of companion animals and the phenomenon of pet humanization are fundamentally altering the veterinary services landscape, leading to increased expenditure on diagnostic and preventative healthcare. As owners increasingly view pets as family members, their willingness to pay for sophisticated medical testing has grown, incentivizing clinics to upgrade their on-site testing capabilities. This trend is reflected in the American Pet Products Association's August 2024 report, which noted that total U.S. spending on veterinary care and products reached $39.8 billion in 2024. Leading industry players further evidence this demand; IDEXX Laboratories reported full-year 2024 revenues of $3.898 billion in 2025, underscoring the lucrative nature of the diagnostics sector driven by these dual market forces.

Market Challenge

The primary obstacle to market expansion is the prohibitive cost associated with acquiring and operating advanced molecular diagnostic technologies. These sophisticated testing platforms require substantial capital investment and rely on expensive reagents, creating a high barrier to entry for livestock producers and veterinary clinics with limited budgets. In price-sensitive agricultural sectors and developing regions, these financial demands often force practitioners to rely on traditional, less accurate methods rather than adopting modern diagnostic solutions, thereby stifling the market's potential reach in areas where infectious risks are frequently highest.

This economic strain is exacerbated by the broader escalating costs of animal healthcare, which limit the disposable income available for premium diagnostic services. According to the American Animal Hospital Association, the lifetime cost of care for a dog increased by 11.65% in 2025 compared to 2022 levels. Such rising expenses compel farmers and pet owners to scrutinize spending, often resulting in the rejection of high-cost diagnostic procedures in favor of basic symptomatic treatments. Consequently, this financial reticence directly hampers revenue growth and the widespread global adoption of advanced diagnostic tools.

Market Trends

The integration of Artificial Intelligence and Machine Learning into diagnostics is fundamentally reshaping veterinary practice by automating complex analytical tasks and improving diagnostic accuracy. This trend addresses the shortage of specialists by embedding deep learning algorithms into analyzers, allowing practitioners to obtain reference-quality interpretations for cytology and hematology in real-time. This technological leap is evidenced by recent advancements; in December 2024, Zoetis Inc. announced AI-driven updates to its Vetscan Imagyst platform, including a new algorithm capable of identifying and differentiating white blood cells within minutes, thereby streamlining the diagnostic workflow.

Concurrently, the adoption of Point-of-Care and Rapid Diagnostic Testing is shifting infectious disease management from central laboratories to the clinic, facilitating immediate pathogen detection. By utilizing on-site analyzers, veterinarians can rapidly implement biosecurity measures and treatment plans, a capability essential for controlling contagious outbreaks. The market's pivot toward these solutions is quantified by financial performance; IDEXX Laboratories, Inc. reported in October 2024 a 10% year-over-year growth in its global premium instrument installed base, underscoring the increasing investment by practices in rapid, in-house diagnostic infrastructure.

Key Market Players

  • BIOMeRIEUX
  • Heska Corporation
  • Neogen Corporation
  • INDICAL BIOSCIENCE GmbH
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • DRG INSTRUMENTS GMBH
  • Chembio Diagnostic Systems, Inc.
  • Eurofins Technologies
  • Agrolabo S.p.A.
  • Abbott Laboratories inc.
  • Danaher Corporation

Report Scope

In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Infectious Disease Diagnostics Market, By Technology

  • Immunodiagnostics
  • Molecular Diagnostics
  • Other Veterinary Diagnostic Technologies

Veterinary Infectious Disease Diagnostics Market, By Animal Type

  • Companion Animals
  • Food Producing Animals

Veterinary Infectious Disease Diagnostics Market, By End User

  • Reference Laboratories
  • Veterinary Laboratories and Clinics
  • Point of Care / In House Testing
  • Research Institutes and Universities

Veterinary Infectious Disease Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Infectious Disease Diagnostics Market.

Available Customizations:

Global Veterinary Infectious Disease Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Infectious Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies)
    • 5.2.2. By Animal Type (Companion Animals, Food Producing Animals)
    • 5.2.3. By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Infectious Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Animal Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Infectious Disease Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Veterinary Infectious Disease Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Veterinary Infectious Disease Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By End User

7. Europe Veterinary Infectious Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Animal Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Infectious Disease Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Veterinary Infectious Disease Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Veterinary Infectious Disease Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Veterinary Infectious Disease Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Veterinary Infectious Disease Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Veterinary Infectious Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Animal Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Infectious Disease Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Veterinary Infectious Disease Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Veterinary Infectious Disease Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Veterinary Infectious Disease Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Veterinary Infectious Disease Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Animal Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Infectious Disease Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Veterinary Infectious Disease Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Veterinary Infectious Disease Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By End User

10. South America Veterinary Infectious Disease Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Animal Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Infectious Disease Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Veterinary Infectious Disease Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Veterinary Infectious Disease Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Infectious Disease Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BIOMeRIEUX
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Heska Corporation
  • 15.3. Neogen Corporation
  • 15.4. INDICAL BIOSCIENCE GmbH
  • 15.5. Randox Laboratories Ltd.
  • 15.6. Thermo Fisher Scientific Inc.
  • 15.7. Creative Diagnostics
  • 15.8. DRG INSTRUMENTS GMBH
  • 15.9. Chembio Diagnostic Systems, Inc.
  • 15.10. Eurofins Technologies
  • 15.11. Agrolabo S.p.A.
  • 15.12. Abbott Laboratories inc.
  • 15.13. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer